STOCK TITAN

Omnicell Inc - OMCL STOCK NEWS

Welcome to our dedicated page for Omnicell news (Ticker: OMCL), a resource for investors and traders seeking the latest updates and insights on Omnicell stock.

Omnicell Inc. (OMCL) is a pioneering company that has been enhancing efficiencies in healthcare since 1992. As a leading supplier of comprehensive automation and business analytics software, Omnicell focuses on patient-centric medication and supply management across the entire healthcare continuum. This includes acute care hospital settings, post-acute skilled nursing and long-term care facilities, as well as home care settings.

Omnicell's automated hardware/software systems for medication dispensing provide seamless solutions from the point of hospital entry to the central pharmacy, nursing units, operating rooms, and patient bedsides. Their supply management systems are designed to promote cost control, ensure charge capture for payer reimbursement, and facilitate efficient inventory management and reordering.

Omnicell's range of products includes high-security, closed-cabinet systems, open-shelf systems, and combination systems that are used in nursing units, cath labs, and operating rooms. These solutions empower pharmacists and nurses to concentrate on patient care rather than administrative tasks, driving improved clinical, operational, and financial outcomes across diverse care settings. With over 3,200 customers worldwide, Omnicell continues to be a trusted partner in the healthcare sector.

In recent years, Omnicell has made significant strides in advancing their technology and expanding their service offerings. Their commitment to innovation is evident in the development of new products and partnerships that aim to further streamline medication management processes. Financially, the company generates the majority of its revenue in the United States, reflecting a strong market presence and consistent performance.

Rhea-AI Summary
Omnicell, Inc. announces Q3 2023 results with total GAAP revenues of $299 million, down 14% YoY. GAAP net income per diluted share was $0.12, while non-GAAP net income per diluted share was $0.62. The company plans to take cost containment actions, including a headcount reduction, with expected non-recurring charges of $12 million - $18 million. Omnicell expects full-year 2023 revenues to be between $1.135 billion and $1.155 billion, with non-GAAP earnings per share between $1.65 and $1.80.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.26%
Tags
-
Rhea-AI Summary
Omnicell, Inc. will release its financial results for the third quarter of 2023 on November 2nd. A conference call and webcast will be held to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.33%
Tags
-
Rhea-AI Summary
Omnicell, Inc. to present at 2023 Wells Fargo Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.55%
Tags
conferences
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.67%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.04%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.08%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.68%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.52%
Tags
none
-
Rhea-AI Summary
Omnicell announces the appointment of Nchacha E. Etta as Executive Vice President and Chief Financial Officer, effective June 1, 2023. Mr. Etta brings over 20 years of finance and accounting experience to the company, having previously served in leadership roles at Essilor of America, Johnson & Johnson Vision, The Coca-Cola Company, Microsoft Corporation, and Eli Lilly and Company. Omnicell expects to benefit from Mr. Etta's expertise in finance and accounting, as well as his broader leadership experience, as they continue to focus on their recent acquisitions and operational efficiencies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.26%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.54%
Tags
conferences

FAQ

What is the current stock price of Omnicell (OMCL)?

The current stock price of Omnicell (OMCL) is $45.69 as of November 22, 2024.

What is the market cap of Omnicell (OMCL)?

The market cap of Omnicell (OMCL) is approximately 2.1B.

What is Omnicell Inc. known for?

Omnicell Inc. is known for providing comprehensive automation and business analytics software for patient-centric medication and supply management in healthcare.

When was Omnicell Inc. founded?

Omnicell Inc. was founded in 1992.

What types of healthcare settings does Omnicell serve?

Omnicell serves acute care hospital settings, post-acute skilled nursing and long-term care facilities, and home care settings.

How do Omnicell's products benefit healthcare providers?

Omnicell's products automate medication and supply management, allowing healthcare providers to focus on patient care, improve operational efficiency, and achieve better clinical and financial outcomes.

What kinds of products does Omnicell offer?

Omnicell offers high-security closed-cabinet systems, open-shelf systems, and combination systems used in nursing units, cath labs, and operating rooms.

How many customers does Omnicell have globally?

Omnicell has over 3,200 customers worldwide.

Where does Omnicell generate most of its revenue?

Omnicell generates the majority of its revenue in the United States.

What recent achievements has Omnicell made?

Omnicell has advanced its technology and expanded service offerings, developing new products and partnerships to streamline medication management processes.

How do Omnicell's supply management systems aid healthcare facilities?

Omnicell's supply management systems help healthcare facilities control costs, ensure charge capture for payer reimbursement, and manage inventory efficiently.

What is the primary goal of Omnicell's products and services?

The primary goal of Omnicell's products and services is to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, thereby improving overall clinical, operational, and financial outcomes.

Omnicell Inc

Nasdaq:OMCL

OMCL Rankings

OMCL Stock Data

2.08B
45.50M
1.56%
100.97%
3.59%
Health Information Services
Electronic Computers
Link
United States of America
FORT WORTH